pneumonia, LGV, and psittacosis it is usual to make the diagnosis serologically.
The technique used commonly for serodiagnosis is complement fixation. It is, however, not as sensitive as the microimmunofluorescence (MIF) test,' but this requires fluorescence microscopy with its attendant disadvantages of subjective analysis and the need for skilled operators. The radioisotope-precipitation test2 has been used for detection of antichlamydial antibodies, although the specialised nature of the equipment required puts it beyond the resources of a routine laboratory.
Accepted for publication 22 February 1982 In recent years the enzyme-linked immunosorbent assay (ELISA)3 has been used to detect antibody to a wide range of microbial antigens.4 The assay is claimed to be extremely sensitive, and the results can be read either subjectively by seeking colour changes or objectively by determining absorbance values.
Lewis et alt developed an ELISA for Cpsittaci which involved actively fixing chlamydial elementary bodies to the wells of microtitre plates. We found this method to be of variable reproducibility and have developed an ELISA for C trachomatis, based on passively adsorbed extracted chlamydial group antigen, which is reproducible and sensitive and may be useful diagnostically and epidemiologically.
Material and methods

ANTIGEN PREPARATION
The yolk sacs of 100 seven-day-old fertile hens' eggs were each inoculated with 0-2 ml of a 1/10 dilution of a suspension containing 10'0 inclusion-forming units of chlamydial strain SA2(f)/ml. The eggs were them died the remainder were put at 40C to kill the embryos. Then the yolk sacs of all 100 eggs were harvested, an equal volume of PBS "A" was added and the sacs homogenised in an MSE "Atomix" blender for 3 min. The homogenate was centrifuged at 500 g for 10 min and the supernatant fluid at 12 000 g for 1 h. The resulting supematant fluid was layered on a 20% Urografin (Schering) gradient and centrifuged at 25 000 g for 2 h. The pellet was resuspended in PBS "A" which was layered on a 32% Urografin gradient and centrifuged as before. The pellet was resuspended in 20 ml of PBS "A" to which 2-5 ml of 1% sodium deoxycholate was added and the mixture incubated, with shaking, at 45°C for 4 h. Finally, the mixture was centrifuged at 30 000 g for 20 min and the supernatant fluid constituted the antigen, the required concentration for assays being established by a chequerboard titration.
Complement-fixation (CF) test antigen, extracted from the ovine enzootic abortion strain of C psittaci, and supplied by the Public Health Laboratory Service (PHLS) (Colindale, London), was used in an ELISA in comparison with the antigen described above. SERA Sera were obtained from adult patients attending venereal disease clinics with non-gonococcal urethritis, and rheumatology clinics with suspected Reiter's disease. Sera from 132 children, ranging in age from one week to 12 yr, were obtained from the Clinical Chemistry Department of Northwick Park Hospital. All these sera were frozen at -20°C before being tested. Unfrozen sera from 300 patients with complaints other than venereal disease were obtained from various pathology departments of Northwick Park Hospital. In addition, sera from male chimpanzees6 and female marmosets7 which had been inoculated genitally with strains of C trachomatis isolated from the human genital tract were tested. Sera from uninoculated animals were tested also. The sera from all these animals were kept at -20°C before being tested.
ELISA TECHNIQUE
A 100 jil volume of antigen, diluted to the required concentration in carbonate-bicarbonate buffer (pH 9-6), was added to each well of M29A Microelisa plates (Dynatech Laboratories). The plates were kept at 4°C overnight and then washed four times during a 10 min period with PBS "A"/0-05% Tween 20. Test sera were diluted in PBS/Tween and 100 ,ul added to appropriate wells, after which the plates were kept at 4°C for 3 h arid then washed as before. A 100 ml volume of alkaline phosphatase conjugated to antihuman immunoglobulin (Miles Labs or Don Whitley Scientific) was then added to each well, the appropriate dilution having been determined previously by a chequerboard assay. The plates were kept at 4°C for 3 h and washed as described previously. The substrate was prepared by adding a 5 mg tablet of Sigma 104 PNPP to 5 ml of ELISA Substrate Buffer (Don Whitley) and 100 ,ul were added to each well. The plates were left at room temperature for 30 min after which the results were read, both visually and on a Titertek "Multiskan" microelisa reader at 405 nm.
CHLAMYDIAL ANTIBODY TITRE DETERMINATION
Originally, all sera were diluted from 1/8 to 1/1024 and absorbance values were compared with those for sera known to be antibody negative by the MIF test. Any serum having an absorbance value greater than the mean absorbance value of the negative sera + 2-5 standard deviations was regarded as antibody positive.
Latterly, we used a mathematical method8 to determine the antibody titre. This determines the intercept of the straight line formed by taking the absorbance values (mean + 2 5 standard deviations) for three dilutions of negative sera and the curve fitted to the absorbance values for the same dilutions of test sera. By applying the indicated formula, the antibody titre may be obtained:
where B Y1 -2Y2 + Y3 Moreover, the antibody titre determined by the ELISA was at least twofold greater than by MIF in 53% of the sera, whereas the reverse was seen in only 20% of the sera. Sequential sera from six patients were tested ( Table 2 ). The results on sera from four patients by the ELISA were comparable with those by MIF. There were, however, two patients whose sera behaved differently in the two tests. The titres of antibody in the sera of one patient (Ma) were consistently high as measured by the ELISA but low by MIF, whereas the reverse was seen in the case of another patient (Ke). Twelve of the 75 sera tested previously were examined again by the ELISA using the extracted antigen and also the CF antigen supplied by the PHLS. In addition, the sera were tested by CF using the PHLS antigen. The results, presented in Sera from 300 adult patients attending hospital for reasons not associated with venereally acquired diseases were tested by the ELISA. The results, including those of tests on 132 sera from children, are shown in Table 4 . As mentioned previously, 8 (6%) of the children's sera contained antibody at a titre of l/l16. In comparison, 59 (20%) of the adult sera contained antibody, but only 9 (3%) contained antibody at a titre of 1/3256. This is in contrast to the presence of antibody (titre of 1/¢16) in 64 (85%) of the sera from 75 patients attending venereal disease or rheumatology clinics. 
Discussion
Originally, we attempted to modify the ELISA described for C psittaci by Lewis et al,5 by using, as antigen, chlamydial strain SA2(f) which has been shown to crossreact with the majority of C trachomatis serotypes.'°However, we found that the test behaved in an unpredictable manner, whether we used alkaline-phosphatase-conjugated antiserum or peroxidase-conjugated antiserum. The system we developed eventually is reproducible and the results are easy to interpret visually and by machine provided alkaline-phosphatase conjugates are used. We had hoped to use peroxidase conjugates because the more intense colours they produce would have been easier to interpret visually. However, the "background" coloration we encountered made determination of end-points difficult. This was true irrespective of whether the substrate used was 0-phenylenediamine, dinitrobenzidine, 5-amino-salicylic acid or 2,2-azino-di(3-ethylbenzylthiazoline sulphonic acid). The peroxidase conjugates we used originally were produced by glutaraldehyde linkage." Although it has been suggested that periodate-linked conjugates might give lower "background" absorbance values, '2 we were unable to show this and continued to use alkaline-phosphatase conjugates. Determination of the antibody titre in the ELISA was a problem. There appears to be no standard method of doing this. Some workers have not stated their method whereas others regard the well which contains fluid noticeably darker than the corresponding control as the end-point. In addition, results are presented as ratios of positive to negative absorbance values and also as values greater than an arbitrary fixed value. We decided to use a method employed by several other workers, regarding a serum as "positive' if the absorbance value was equal to or greater than the mean of the absorbance values of several negative sera, at a given dilution, plus 2-5 standard deviations. The mathematical method of determining the antibody titre has several advantages. It provides a precise titre which can be determined by using only three or four dilutions of serum. This, in turn, enables a greater number of assays to be performed in each microtitre plate, with an attendant saving in cost.
The sensitivity of the ELISA for detecting chlamydial antibody was greater than that of the MIF technique and considerably greater than that of the CF test. The specificity of the ELISA may be gauged, to some extent, by the results obtained from examining sera from different groups of persons. Antibody was found infrequently in children, a little more frequently in adults attending a general hospital and was present in almost all the sera of persons attending a venereal disease clinic. These results are consistent with the distrubution of C trachomatis in the population. However, because the ELISA detects antibody directed against the chlamydial group antigen (vide infra), there is no reason to believe that antibody to C psittaci would not be detected by the extracted SA2(f) antigen. The apparent specificity of the ELISA is, therefore, probably a measure of the relatively infrequent occurrence of infection by Cpsittaci.
The results obtained by the ELISA correlated closely with those obtained by MIF in tests on sera from chimpanzees and marmosets that had been infected with C trachomatis. There was good agreement also in comparative tests on human sera. However, with these, the results obtained by the ELISA and by MIF did not always correlate. An explanation for this could be that the MIF technique measures antibody to various antigens on the surface of chlamydiae, whereas the ELISA described here detects antibody only to the group antigen which may be expressed to a lesser extent on the organism surface.
The ELISA we have developed is sensitive, reproducible, capable of being automated and the antibody titres may be determined precisely. In its present form it is undoubtedly an alternative to the CF test. Many laboratories are now equipped to detect antibody against other micro-organisms by ELISA and the technique we describe would be complementary to these assays. Production of antigen is simple and it can be stored in aliquots at -20°C until required. The ELISA results obtained with the PHLS CF antigen indicate that it is a suitable alternative to the antigen we prepared. However, whether the ELISA could be used as an alternative to the MIF technique is open to question. The latter has the advantage of detecting antibodies to the whole range of chlamydial serotypes. Further development of the ELISA is likely to provide it with this attribute.
